Emergency Intraoperative Implantation of ECMO for Refractory Cardiogenic Shock Arising During Liver Transplantation as a Bridge to Myocardial Surgical Revascularization by Lauterio, A et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/transplantjournalby
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3rL6M
iO
W
0w
/P
B
V
ukpTX
giR
bvshD
Y
yA
j5j0bQ
1m
R
fv67U
=
on
01/20/2020
Downloadedfromhttps://journals.lww.com/transplantjournalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3rL6MiOW0w/PBVukpTXgiRbvshDYyAj5j0bQ1mRfv67U=on01/20/2020
Transplantation  ■  October 2019  ■  Volume 103  ■  Number 10 www.transplantjournal.com e317
ISSN: 0041-1337/19/10310-e317
DOI: 10.1097/TP.0000000000002826
Received 30 April 2019. Revision received 17 May 2019.
Accepted 21 May 2019.
1 Department of General Surgery & Abdominal Transplantation, ASST Grande 
Ospedale Metropolitano Niguarda, Milan, Italy.
2 Departments of Surgical Sciences, University of Pavia, Pavia, Italy.
3 Division of Cardiac Surgery, ASST Grande Ospedale Metropolitano Niguarda, 
Milan, Italy.
4 Division of Anaesthesia, ASST Grande Ospedale Metropolitano Niguarda, 
Milan, Italy.
5 School of Medicine, University of Milano-Bicocca, Milan, Italy.
The authors declare no funding or conflicts of interest.
A.L. proposed the letter, wrote, and reviewed the manuscript. R.D.C. collected 
clinical data and corrected the manuscript. A.C. collected clinical data and 
corrected the manuscript. S.D.S., A.D.G., C.R., and L.D.C. corrected the 
manuscript. 
Correspondence: Andrea Lauterio, MD, Department of General Surgery 
and Abdominal Transplantation, ASST Grande Ospedale Metropolitano 
Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy. (andrea.lauterio@
ospedaleniguarda.it).
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. 
Emergency Intraoperative Implantation of ECMO 
for Refractory Cardiogenic Shock Arising During 
Liver Transplantation as a Bridge to Myocardial 
Surgical Revascularization
Andrea Lauterio, MD,1 Riccardo  De Carlis, MD,1,2 Aldo Cannata, MD,3 Stefano Di Sandro, MD, PhD,1 
Andrea De Gasperi, MD,4 Claudio Russo, MD,3 and Luciano De Carlis, MD1,5
We read with interest the article by Braun et al1 on the utility of extracorporeal membrane oxygena-
tion (ECMO) after liver transplantation (LT).
Every ECMO application during LT is unique, and there 
should be mandatory reporting of every incident to build a 
body of experience for the benefit of all.
A 53-year-old male, with hepatocellular carcinoma on 
a background of hepatitis C virus-related cirrhosis, under-
went LT from a brain-dead donor in July 2018.
The donor was a 60-year-old man with no comorbidi-
ties, body mass index of 27, who had died of a stroke; he 
had been in the intensive care unit 2 days before organ 
procurement. Liver biopsy showed only mild macrosteato-
sis (<20%) and no other histological abnormalities.
Before LT the recipient’s cardiac assessment was per-
formed according to our standard protocol. A transtho-
racic echocardiography showed a 71% left ventricular 
ejection fraction, while a rest/stress dipyridamole scintig-
raphy showed normal myocardial perfusion.
The estimated blood loss before reperfusion was 
1800 mL, while the graft cold ischemia time lasted 8 hours 
and 30 minutes.
Upon graft reperfusion, we observed severe worsen-
ing of the hemodynamic profile that resulted in a cardiac 
arrest. Cardiopulmonary resuscitation was initiated by 
the surgeon, and after external cardiac massage (45 min), 
pharmacological treatment, and 4 transthoracic defibril-
lation attempts, the patient’s hemodynamic responded to 
resuscitation recovering spontaneous cardiac rhythm.
Subsequently, the electrocardiogram showed diffuse 
signs of severe myocardial ischemia, while a transthoracic 
echocardiography showed severe hypoakinesia of the left 
ventricle.
At the end of the arterial anastomoses, recurring car-
diac arrests necessitated continuation of cardiopulmonary 
resuscitation, making it impossible to proceed with the 
surgical procedure.
Given the severe cardiogenic shock and risk of intraop-
erative death, venoarterial (VA) ECMO was instituted by 
means of cannulation of the common femoral artery and 
vein by the cardiac surgeons.
The biliary anastomosis and abdomen closure were 
performed during the VA-ECMO support, after which the 
patient was transferred to undergo urgent invasive coro-
nary angiography that showed an unexpected severe mul-
tivessel coronary artery disease.
Two coronary bypasses were performed during 
VA-ECMO support instead of a percutaneous approach to 
avoid the high bleeding risk associated with dual antiplate-
let therapy in this clinical context.
The patient was successfully weaned off ECMO 4 days 
after the LT with a 55% left ventricular ejection fraction 
and no bleeding or thrombotic events.
Alanine aminotransferase and aspartate aminotrans-
ferase levels peaked at 1460 and 1240 IU/mL, respectively, 
on postoperative day 2, while bilirubin remained <10 mg/
dL. Liver graft function improved gradually to normal 
before patient discharge. Despite exposure to periopera-
tive and postoperative risk factors for acute kidney injury, 
the patient did not require posttransplant renal replace-
ment therapy.
No complications of LT or VA-ECMO were found and 
the patient was discharged on postoperative day 26 and is 
still alive and well 10 months later.
Cardiovascular complications related to reperfusion 
syndrome contribute to nongraft–related intraoperative 
and perioperative mortality during LT.2
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Impaired hemodynamics during LT, exacerbated by sig-
nificant reperfusion syndrome, can unmask latent cardio-
vascular disease either perioperatively or immediately after 
transplant.
Pretransplant cardiovascular risk assessment in LT recip-
ients still holds a degree of uncertainty in pretransplant 
evaluation because current noninvasive tests to evaluate 
subclinical coronary artery disease have low sensitivity.3 
However, limited guidelines on the cardiac assessment of 
LT recipients have been reported.3,4
In the case reported, VA-ECMO proved an effective 
extreme strategy in the event of severe refractory cardio-
genic shock during LT, allowing us to complete the trans-
plant and provide a bridge to myocardial revascularization.
We would like to point out that effective collabora-
tion within teams and between specialties was crucial to 
handle an extremely grave situation and facilitated posi-
tive patient outcome.
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